Related Experiment Video
Updated: Jul 10, 2026

A Test Bed to Examine Helmet Fit and Retention and Biomechanical Measures of Head and Neck Injury in Simulated Impact
Published on: September 21, 2017
AI product liability under EU and Canadian laws
1College of Law, Prince Sultan University, Riyadh, Saudi Arabia.
None:
AI and AI-enabled product-related liability have been a concern for the industries and consumers. They would like clarity on the liability for defective AI systems or products to mitigate risks. Laws in many countries provide tort or strict liability to address product liability. Some countries are amending or seeking to amend existing product liability legislation to address new issues related to AI. The EU has passed new directives and amended existing ones to address AI product liability, while Canada has drafted a new law to address this issue. The article aimed to assess the available literature and identify gaps in AI product liability. It also investigates the rules in the EU and Canada regarding AI product liability. By doing so, it intended to suggest improvements to the Canadian law on AI product liability. To achieve the objective, the researcher utilized a systematic literature review, legal doctrinal research, and comparative legal method. The finding showed that proving fault in an AI environment is challenging. Therefore, strict liability or a rebuttable presumption of causation could effectively protect end users. It will also ensure that various parties involved in AI take necessary safety measures to meet the legal presumption of their liability. It further revealed that the EU regulatory framework addresses AI product liability more effectively, although it has a few weaknesses that need to be addressed. The article suggested improvements to Canadian law regarding proof of fault, personal remedies, the role of the court, and the parties' liability.
Related Concept Videos
Drug Products: Biologics, Biosimilars and Interchangeables
Drug Regulation
Bioequivalence studies: Biowaivers
Torts III
Quasi-intentional torts in healthcare involve acts where intent is not directed to harm an individual but results in harm due to careless or reckless speech.
Torts I
Intentional...
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...

